BMY Bristol Myers Squibb Co

   By Austen Hufford 
 

Bristol-Myers Squibb Co. (BMY) reported results for its first quarter Thursday. Here's what you need to know:

REVENUE: The drug maker said revenue rose 5% to $5.19 billion. Analysts polled by Thomson Reuters had expected revenue of $5.23 billion.

PROFIT: Net income came in at $1.49 billion, or 91 cents a share, compared with $1.57 billion, or 94 cents a share, in the year-ago quarter. On an adjusted basis, earnings came in at 94 cents a share, above the 85 cents a share expected by analysts.

OUTLOOK: The company raised its adjusted EPS outlook. It now expects 2018 EPS to come in at $3.35 to $3.45, up from $3.15 - $3.30 previously.

NOTEABLE DRUGS: Cancer-drug Opdivo saw 34% growth to $1.51 billion. Anticoagulant Eliquis rose 37% to $1.51 billion.

Write to Austen Hufford at Austen.Hufford@wsj.com

(END) Dow Jones Newswires

April 26, 2018 07:25 ET (11:25 GMT)

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024